JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1995) 14, 209-226    DOI: 10.1677/jme.0.0140209
© 1995 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klett, C
Right arrow Articles by Hackenthal, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klett, C
Right arrow Articles by Hackenthal, E

Contribution of a 12 kDa protein to the angiotensin II-induced stabilization of angiotensinogen mRNA: interaction with the 3' untranslated mRNA

C Klett, M Bader, M Schwemmle, D Ganten and E Hackenthal

Several authors have shown that angiotensin II stimulates hepatic angiotensinogen synthesis in vivo, ex vivo and in vitro. In previous studies we have demonstrated that this effect of angiotensin II depends mainly on a transient inhibition of adenylyl cyclase and is the consequence of a stabilization of angiotensinogen mRNA. In the present study we describe the isolation of a polysomal 12 kDa protein which, in band shift and cross link assays, shows a specific affinity to the 3' untranslated region (3' UTR) of angiotensinogen mRNA and prevents enzymatic degradation of angiotensinogen mRNA in a cell-free incubation system. [32P]UTP-labelled or unlabelled 3' fragments of angiotensinogen mRNA were synthesized on a transcription vector (pGEM5zf+) into which the corresponding DNA sequence was cloned after restriction from vector pRAG 16. Binding of the 12 kDa protein to the radioactively labelled 3' UTR of angiotensinogen mRNA could be displaced by unlabelled 3' UTR mRNA fragments but not by a renin mRNA of comparable length derived from the coding region, The RNA-binding protein appears to be derived from a higher molecular mass precursor (45 kDa) which is preferentially present under reducing conditions in vitro; the active low molecular mass form is evident in the absence of reducing agents. In a cross link experiment we established that a band shift signal which was obtained in the presence of the 45 kDa protein preparation exclusively depends on RNA binding of the active 12 kDa protein. In addition, a phosphorylation step may be involved in the activation of the 12 kDa protein, since its molecular mass and isoelectric point correlate with proteins which were phosphorylated in response to transient decreases of cAMP (induced by guanfacine or angiotensin II) or in response to a direct inhibition of protein kinase A by the cAMP antagonist Rp-cAMP. The importance of phosphorylation reactions for the stabilization of angiotensinogen mRNA was further assessed in a cell-free incubation system of rat liver parenchymal cells. These studies demonstrated that in the presence of acid phosphatase (1 U/ml) the half-life of angiotensinogen was significantly decreased. In the same incubation system the 12 kDa protein increased the half-life of endogenous as well as of exogenous angiotensinogen mRNA three- to fourfold, while no stabilizing effect was apparent when exogenous angiotensinogen mRNA from which the 3' tail had been deleted was added. We concluded that an intracellular 12 kDa protein may play a crucial role in the angiotensin Il-induced stabilization of hepatic angiotensinogen mRNA and further suggest that this protein exerts its effect via binding to the 3' UTR of angiotensinogen mRNA in response to a cAMP-dependent activation step.




This article has been cited by other articles:


Home page
IOVSHome page
P. deS. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, K. Nishiyama, S.-I. Miura, S. Karnik, J. E. Sears, and J. G. Hollyfield
Angiotensin II and Its Receptor Subtypes in the Human Retina
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3301 - 3311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. P. R. Klett, D. Anderson, M. Sholook, and J. P. Granger
Antisense oligodeoxynucleotides directed against a novel angiotensinogen mRNA-stabilizing protein reduce blood pressure in spontaneously hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R619 - R626.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Olivi, J. Sisk, and J. Bressler
Involvement of DMT1 in uptake of Cd in MDCK cells: role of protein kinase C
Am J Physiol Cell Physiol, September 1, 2001; 281(3): C793 - C800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Kontogiannis and K. D. Burns
Role of AT1 angiotensin II receptors in renal ischemic injury
Am J Physiol Renal Physiol, January 1, 1998; 274(1): F79 - F90.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Bohlender, J. Menard, F. C. Luft, and D. Ganten
Dose Effects of Human Renin in Rats Transgenic for Human Angiotensinogen
Hypertension, April 1, 1997; 29(4): 1031 - 1038.
[Abstract] [Full Text]


Home page
HypertensionHome page
B. Erdmann, K. Fuxe, and D. Ganten
Subcellular Localization of Angiotensin II Immunoreactivity in the Rat Cerebellar Cortex
Hypertension, November 1, 1996; 28(5): 818 - 824.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Society for Endocrinology.